TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this cluster in csv format
Share this page

Variant cluster associations

Hospitalization Episode Statistics (HES)

Cluster X0272
log Bayes Factor = 22.1927
contains 2 variants:
rs13129697
lBF = 17.687
Chr 4 : 9,926,967
rs454768
lBF = 5.281
Chr18 : 29,628,863
What are variant clusters?
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M10.99 Gout, unspecified (Site unspecified)
0.000 0.000 1.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
1.000 0.000 0.000
M10.9 Gout, unspecified
0.000 0.000 1.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.999 0.001 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.996 0.004 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.996 0.004 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.995 0.005 0.000
M10.96 Gout, unspecified (Lower leg)
0.000 0.007 0.993
C83 Diffuse non-Hodgkin's lymphoma
0.986 0.014 0.000
M10.97 Gout, unspecified (Ankle and foot)
0.000 0.015 0.985
C91 Lymphoid leukaemia
0.977 0.023 0.000
C95 Leukaemia of unspecified cell type
0.951 0.049 0.000
C91.4 Hairy-cell leukaemia
0.948 0.052 0.000
M10.94 Gout, unspecified (Hand)
0.000 0.056 0.944
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.926 0.074 0.000
C83.0 Small cell (diffuse)
0.915 0.085 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.910 0.090 0.000
M10.92 Gout, unspecified (Upper arm)
0.000 0.107 0.893
C95.9 Leukaemia, unspecified
0.888 0.112 0.000
C90.0 Multiple myeloma
0.866 0.134 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.866 0.134 0.000
C88 Malignant immunoproliferative diseases
0.857 0.143 0.000
M10.90 Gout, unspecified (Multiple sites)
0.000 0.169 0.831
C83.5 Lymphoblastic (diffuse)
0.817 0.183 0.000
C95.0 Acute leukaemia of unspecified cell type
0.803 0.197 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.801 0.199 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.788 0.212 0.000
C91.1 Chronic lymphocytic leukaemia
0.785 0.215 0.000
C82.0 Small cleaved cell, follicular
0.782 0.217 0.000
C82.4 Follicular lymphoma grade IIIb
0.780 0.220 0.000
C91.0 Acute lymphoblastic leukaemia
0.773 0.227 0.000
C83.7 Burkitt's tumour
0.772 0.228 0.000
C82.3 Follicular lymphoma grade IIIa
0.766 0.233 0.000
C93 Monocytic leukaemia
0.752 0.248 0.000
C85.1 B-cell lymphoma, unspecified
0.748 0.252 0.000
C82.2 Large cell, follicular
0.748 0.252 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.746 0.254 0.000
C81 Hodgkin's disease
0.734 0.266 0.000
C83.3 Large cell (diffuse)
0.731 0.269 0.000
C94 Other leukaemias of specified cell type
0.726 0.274 0.000
C86 Other specified types of T/NK-cell lymphoma
0.724 0.276 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.717 0.283 0.000
M10.91 Gout, unspecified (Shoulder region)
0.000 0.283 0.717
M10.95 Gout, unspecified (Pelvic region and thigh)
0.000 0.283 0.717
M10.98 Gout, unspecified (Other)
0.000 0.283 0.717
C85.0 Lymphosarcoma
0.716 0.284 0.000
C82.5 Diffuse follicle centre lymphoma
0.714 0.285 0.000
C82.6 Cutaneous follicle centre lymphoma
0.714 0.285 0.000
C91.5 Adult T-cell leukaemia
0.707 0.293 0.000
C83.2 Mixed small and large cell (diffuse)
0.707 0.293 0.000
C83.4 Immunoblastic (diffuse)
0.707 0.293 0.000
C83.6 Undifferentiated (diffuse)
0.707 0.293 0.000
C84.5 Other and unspecified T-cell lymphomas
0.705 0.295 0.000
C90.1 Plasma cell leukaemia
0.701 0.299 0.000
C91.2 Subacute lymphocytic leukaemia
0.700 0.299 0.000
C91.3 Prolymphocytic leukaemia
0.700 0.299 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.700 0.299 0.000
C91.7 Other lymphoid leukaemia
0.700 0.299 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.700 0.299 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.682 0.318 0.000
C95.7 Other leukaemia of unspecified cell type
0.682 0.318 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.676 0.324 0.000
C91.9 Lymphoid leukaemia, unspecified
0.662 0.338 0.000
C83.1 Small cleaved cell (diffuse)
0.659 0.341 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.631 0.369 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.622 0.377 0.000
C88.1 Alpha heavy chain disease
0.614 0.386 0.000
C88.2 Gamma heavy chain disease
0.614 0.386 0.000
C88.3 Immunoproliferative small intestinal disease
0.614 0.386 0.000
C88.7 Other malignant immunoproliferative diseases
0.614 0.386 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.614 0.386 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.611 0.389 0.000
C81.7 Other Hodgkin's disease
0.605 0.395 0.000
C90.2 Plasmacytoma, extramedullary
0.600 0.400 0.000
C92 Myeloid leukaemia
0.591 0.409 0.000
C81.0 Lymphocytic predominance
0.583 0.417 0.000
C84.1 Sezary's diease
0.574 0.426 0.000
C84.2 T-zone lymphoma
0.574 0.426 0.000
C84.3 Lymphoepithelioid lymphoma
0.574 0.426 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.574 0.426 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.574 0.426 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.574 0.426 0.000
M10.93 Gout, unspecified (Forearm)
0.000 0.426 0.574
C93.1 Chronic monocytic leukaemia
0.574 0.426 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.566 0.433 0.000
C81.2 Mixed cellularity
0.547 0.452 0.000
C93.0 Acute monocytic leukaemia
0.539 0.461 0.000
C93.2 Subacute monocytic leukaemia
0.539 0.461 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.539 0.461 0.000
C93.7 Other monocytic leukaemia
0.539 0.461 0.000
C93.9 Monocytic leukaemia, unspecified
0.539 0.461 0.000
C84.0 Mycosis fungoides
0.537 0.463 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.530 0.470 0.000
C81.1 Nodular sclerosis
0.527 0.473 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.526 0.474 0.000
C81.3 Lymphocytic depletion
0.526 0.474 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.526 0.474 0.000
C84.4 Peripheral T-cell lymphoma
0.521 0.478 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.521 0.479 0.000
C94.1 Chronic erythraemia
0.521 0.479 0.000
C94.2 Acute megakaryoblastic leukaemia
0.521 0.479 0.000
C94.3 Mast cell leukaemia
0.521 0.479 0.000
C94.4 Acute panmyelosis
0.521 0.479 0.000
C94.5 Acute myelofibrosis
0.521 0.479 0.000
C94.7 Other specified leukaemias
0.521 0.479 0.000
C90.3 Solitary plasmacytoma
0.519 0.481 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.519 0.481 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.519 0.481 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.519 0.481 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.519 0.481 0.000
C86.4 Blastic NK-cell lymphoma
0.519 0.481 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.519 0.481 0.000
C96.0 Letterer-Siwe disease
0.514 0.486 0.000
C96.1 Malignant histiocytosis
0.514 0.486 0.000
C96.2 Malignant mast cell tumour
0.514 0.486 0.000
C96.3 True histiocytic lymphoma
0.514 0.486 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.514 0.486 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.514 0.486 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.514 0.486 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.514 0.486 0.000
C96.8 Histiocytic sarcoma
0.514 0.486 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.514 0.486 0.000
C92.7 Other myeloid leukaemia
0.468 0.532 0.000
C92.4 Acute promyelocytic leukaemia
0.466 0.534 0.000
C92.5 Acute myelomonocytic leukaemia
0.435 0.565 0.000
C92.2 Subacute myeloid leukaemia
0.424 0.576 0.000
C92.3 Myeloid sarcoma
0.424 0.576 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.424 0.576 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.424 0.576 0.000
M10 Gout
0.000 0.589 0.411
C92.9 Myeloid leukaemia, unspecified
0.364 0.636 0.000
C92.1 Chronic myeloid leukaemia
0.363 0.637 0.000
M10.1 Lead-induced gout
0.000 0.705 0.295
M10.2 Drug-induced gout
0.000 0.705 0.295
M10.3 Gout due to impairment of renal function
0.000 0.705 0.295
M10.4 Other secondary gout
0.000 0.705 0.295
M10.0 Idiopathic gout
0.000 0.710 0.290
C92.0 Acute myeloid leukaemia
0.282 0.718 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.276 0.723 0.001
C81.9 Hodgkin's disease, unspecified
0.256 0.744 0.000
M10.09 Idiopathic gout (Site unspecified)
0.000 0.758 0.242
M10.10 Lead-induced gout (Multiple sites)
0.000 0.788 0.211
M10.11 Lead-induced gout (Shoulder region)
0.000 0.788 0.211
M10.12 Lead-induced gout (Upper arm)
0.000 0.788 0.211
M10.13 Lead-induced gout (Forearm)
0.000 0.788 0.211
M10.14 Lead-induced gout (Hand)
0.000 0.788 0.211
M10.15 Lead-induced gout (Pelvic region and thigh)
0.000 0.788 0.211
M10.16 Lead-induced gout (Lower leg)
0.000 0.788 0.211
M10.17 Lead-induced gout (Ankle and foot)
0.000 0.788 0.211
M10.18 Lead-induced gout (Other)
0.000 0.788 0.211
M10.19 Lead-induced gout (Site unspecified)
0.000 0.788 0.211
M10.20 Drug-induced gout (Multiple sites)
0.000 0.788 0.211
M10.21 Drug-induced gout (Shoulder region)
0.000 0.788 0.211
M10.22 Drug-induced gout (Upper arm)
0.000 0.788 0.211
M10.23 Drug-induced gout (Forearm)
0.000 0.788 0.211
M10.24 Drug-induced gout (Hand)
0.000 0.788 0.211
M10.25 Drug-induced gout (Pelvic region and thigh)
0.000 0.788 0.211
M10.26 Drug-induced gout (Lower leg)
0.000 0.788 0.211
M10.27 Drug-induced gout (Ankle and foot)
0.000 0.788 0.211
M10.28 Drug-induced gout (Other)
0.000 0.788 0.211
M10.29 Drug-induced gout (Site unspecified)
0.000 0.788 0.211
M10.30 Gout due to impairment of renal function (Multiple sites)
0.000 0.788 0.211
M10.31 Gout due to impairment of renal function (Shoulder region)
0.000 0.788 0.211
M10.32 Gout due to impairment of renal function (Upper arm)
0.000 0.788 0.211
M10.33 Gout due to impairment of renal function (Forearm)
0.000 0.788 0.211
M10.34 Gout due to impairment of renal function (Hand)
0.000 0.788 0.211
M10.35 Gout due to impairment of renal function (Pelvic region and thigh)
0.000 0.788 0.211
M10.36 Gout due to impairment of renal function (Lower leg)
0.000 0.788 0.211
M10.37 Gout due to impairment of renal function (Ankle and foot)
0.000 0.788 0.211
M10.38 Gout due to impairment of renal function (Other)
0.000 0.788 0.211
M10.39 Gout due to impairment of renal function (Site unspecified)
0.000 0.788 0.211
M10.40 Other secondary gout (Multiple sites)
0.000 0.788 0.211
M10.41 Other secondary gout (Shoulder region)
0.000 0.788 0.211
M10.42 Other secondary gout (Upper arm)
0.000 0.788 0.211
M10.43 Other secondary gout (Forearm)
0.000 0.788 0.211
M10.44 Other secondary gout (Hand)
0.000 0.788 0.211
M10.45 Other secondary gout (Pelvic region and thigh)
0.000 0.788 0.211
M10.46 Other secondary gout (Lower leg)
0.000 0.788 0.211
M10.47 Other secondary gout (Ankle and foot)
0.000 0.788 0.211
M10.48 Other secondary gout (Other)
0.000 0.788 0.211
M10.49 Other secondary gout (Site unspecified)
0.000 0.788 0.211
M10.00 Idiopathic gout (Multiple sites)
0.000 0.792 0.208
M10.01 Idiopathic gout (Shoulder region)
0.000 0.792 0.208
M10.02 Idiopathic gout (Upper arm)
0.000 0.792 0.208
M10.03 Idiopathic gout (Forearm)
0.000 0.792 0.208
M10.04 Idiopathic gout (Hand)
0.000 0.792 0.208
M10.05 Idiopathic gout (Pelvic region and thigh)
0.000 0.792 0.208
M10.08 Idiopathic gout (Other)
0.000 0.792 0.208
M10.07 Idiopathic gout (Ankle and foot)
0.000 0.813 0.187
M10.06 Idiopathic gout (Lower leg)
0.000 0.828 0.171
E34.0 Carcinoid syndrome
0.021 0.979 0.000
E34 Other endocrine disorders
0.018 0.982 0.000
E34.9 Endocrine disorder, unspecified
0.018 0.982 0.000
E34.8 Other specified endocrine disorders
0.015 0.985 0.000
E34.3 Short stature, not elsewhere classified
0.014 0.986 0.000
E34.1 Other hypersecretion of intestinal hormones
0.013 0.987 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.013 0.987 0.000
E34.4 Constitutional tall stature
0.013 0.987 0.000
E34.5 Androgen resistance syndrome
0.013 0.987 0.000
M54.89 Other dorsalgia (Site unspecified)
0.009 0.991 0.000
M54.84 Other dorsalgia (Thoracic region)
0.009 0.991 0.000
M54.8 Other dorsalgia
0.009 0.991 0.000
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)
0.009 0.991 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.008 0.992 0.000
Z29.2 Other prophylactic chemotherapy
0.007 0.993 0.000
Z29.8 Other specified prophylactic measures
0.007 0.993 0.000
Z29 Need for other prophylactic measures
0.007 0.993 0.000
M54.86 Other dorsalgia (Lumbar region)
0.007 0.993 0.000
Z00.0 General medical examination
0.007 0.993 0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)
0.007 0.993 0.000
M54.82 Other dorsalgia (Cervical region)
0.007 0.993 0.000
M54.83 Other dorsalgia (Cervicothoracic region)
0.007 0.993 0.000
M54.85 Other dorsalgia (Thoracolumbar region)
0.007 0.993 0.000
M54.87 Other dorsalgia (Lumbosacral region)
0.007 0.993 0.000
M54.80 Other dorsalgia (Multiple sites in spine)
0.007 0.993 0.000
Z29.0 Isolation
0.007 0.993 0.000
J32.2 Chronic ethmoidal sinusitis
0.006 0.994 0.000
V18.0 Driver injured in nontraffic accident
0.000 0.994 0.006
C34.3 Lower lobe, bronchus or lung
0.000 0.994 0.006
M05-M14 Inflammatory polyarthropathies
0.000 0.994 0.006
K07.6 Temporomandibular joint disorders
0.000 0.994 0.006
M12 Other specific arthropathies
0.000 0.994 0.006
Z29.9 Prophylactic measure, unspecified
0.005 0.994 0.000
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
0.005 0.995 0.000
M12.2 Villonodular synovitis (pigmented)
0.000 0.995 0.005
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.005 0.995 0.000
M89.09 Algoneurodystrophy (Site unspecified)
0.005 0.995 0.000
Z75.2 Other waiting period for investigation and treatment
0.000 0.995 0.005
M12.3 Palindromic rheumatism
0.000 0.995 0.005
G62.8 Other specified polyneuropathies
0.000 0.995 0.005
M08 Juvenile arthritis
0.000 0.995 0.005
M09 Juvenile arthritis in diseases classified elsewhere
0.000 0.995 0.005
Z20 Contact with and exposure to communicable diseases
0.005 0.995 0.000
M89.0 Algoneurodystrophy
0.005 0.995 0.000
M12.26 Villonodular synovitis (pigmented) (Lower leg)
0.000 0.995 0.004
M12.24 Villonodular synovitis (pigmented) (Hand)
0.000 0.996 0.004
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts
0.004 0.996 0.000
M89.04 Algoneurodystrophy (Hand)
0.004 0.996 0.000
M12.0 Chronic postrheumatic arthropathy [Jaccoud]
0.000 0.996 0.004
M12.1 Kaschin-Beck disease
0.000 0.996 0.004
M12.4 Intermittent hydrarthrosis
0.000 0.996 0.004
M12.8 Other specific arthropathies, not elsewhere classified
0.000 0.996 0.004
C78.2 Secondary malignant neoplasm of pleura
0.000 0.996 0.004
M13.95 Arthritis, unspecified (Pelvic region and thigh)
0.000 0.996 0.004
Z24 Need for immunisation against certain single viral diseases
0.004 0.996 0.000
M12.39 Palindromic rheumatism (Site unspecified)
0.000 0.996 0.004
M12.5 Traumatic arthropathy
0.000 0.996 0.004
Z20.8 Contact with and exposure to other communicable diseases
0.004 0.996 0.000
M12.20 Villonodular synovitis (pigmented) (Multiple sites)
0.000 0.996 0.004
M12.21 Villonodular synovitis (pigmented) (Shoulder region)
0.000 0.996 0.004
M12.22 Villonodular synovitis (pigmented) (Upper arm)
0.000 0.996 0.004
M12.23 Villonodular synovitis (pigmented) (Forearm)
0.000 0.996 0.004
M12.25 Villonodular synovitis (pigmented) (Pelvic region and thigh)
0.000 0.996 0.004
M12.27 Villonodular synovitis (pigmented) (Ankle and foot)
0.000 0.996 0.004
M12.28 Villonodular synovitis (pigmented) (Other)
0.000 0.996 0.004
M12.29 Villonodular synovitis (pigmented) (Site unspecified)
0.000 0.996 0.004
Z23 Need for immunisation against single bacterial diseases
0.004 0.996 0.000
Z25 Need for immunisation against other single viral diseases
0.004 0.996 0.000
Z26 Need for immunisation against other single infectious diseases
0.004 0.996 0.000
Z27 Need for immunisation against combinations of infectious diseases
0.004 0.996 0.000
Z28 Immunisation not carried out
0.004 0.996 0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction
0.000 0.996 0.004
M89.03 Algoneurodystrophy (Forearm)
0.004 0.996 0.000
M89.06 Algoneurodystrophy (Lower leg)
0.004 0.996 0.000
D06.9 Cervix, unspecified
0.000 0.996 0.004
Z29.1 Prophylactic immunotherapy
0.004 0.996 0.000
Z20.1 Contact with and exposure to tuberculosis
0.004 0.996 0.000
K56.1 Intussusception
0.004 0.996 0.000
O75.7 Vaginal delivery following previous Caesarean section
0.000 0.996 0.004
M71.38 Other bursal cyst (Other)
0.000 0.996 0.004
M12.30 Palindromic rheumatism (Multiple sites)
0.000 0.996 0.003
M12.31 Palindromic rheumatism (Shoulder region)
0.000 0.996 0.003
M12.32 Palindromic rheumatism (Upper arm)
0.000 0.996 0.003
M12.33 Palindromic rheumatism (Forearm)
0.000 0.996 0.003
M12.34 Palindromic rheumatism (Hand)
0.000 0.996 0.003
M12.35 Palindromic rheumatism (Pelvic region and thigh)
0.000 0.996 0.003
M12.36 Palindromic rheumatism (Lower leg)
0.000 0.996 0.003
M12.37 Palindromic rheumatism (Ankle and foot)
0.000 0.996 0.003
M12.38 Palindromic rheumatism (Other)
0.000 0.996 0.003
M89.07 Algoneurodystrophy (Ankle and foot)
0.004 0.996 0.000
M08.0 Juvenile rheumatoid arthritis
0.000 0.996 0.003
M08.1 Juvenile ankylosing spondylitis
0.000 0.996 0.003
M08.2 Juvenile arthritis with systemic onset
0.000 0.996 0.003
M08.3 Juvenile polyarthritis (seronegative)
0.000 0.996 0.003
M08.4 Pauciarticular juvenile arthritis
0.000 0.996 0.003
M08.8 Other juvenile arthritis
0.000 0.996 0.003
M08.9 Juvenile arthritis, unspecified
0.000 0.996 0.003
M09.0 Juvenile arthritis in psoriasis
0.000 0.996 0.003
M09.1 Juvenile arthritis in Crohn's disease [regional enteritis]
0.000 0.996 0.003
M09.2 Juvenile arthritis in ulcerative colitis
0.000 0.996 0.003
M09.8 Juvenile arthritis in other diseases classified elsewhere
0.000 0.996 0.003
M89.01 Algoneurodystrophy (Shoulder region)
0.003 0.996 0.000
M89.02 Algoneurodystrophy (Upper arm)
0.003 0.996 0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)
0.003 0.996 0.000
M89.08 Algoneurodystrophy (Other)
0.003 0.996 0.000
Z20.0 Contact with and exposure to intestinal infectious diseases
0.003 0.996 0.000
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission
0.003 0.996 0.000
Z20.3 Contact with and exposure to rabies
0.003 0.996 0.000
Z20.4 Contact with and exposure to rubella
0.003 0.996 0.000
Z20.5 Contact with and exposure to viral hepatitis
0.003 0.996 0.000
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]
0.003 0.996 0.000
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations
0.003 0.996 0.000
Z20.9 Contact with and exposure to unspecified communicable disease
0.003 0.996 0.000
M14 Arthropathies in other diseases classified elsewhere
0.000 0.996 0.003
M89.00 Algoneurodystrophy (Multiple sites)
0.003 0.996 0.000
Z24.5 Need for immunisation against rubella alone
0.003 0.997 0.000
I89.0 Lymphoedema, not elsewhere classified
0.000 0.997 0.003
M12.00 Chronic postrheumatic arthropathy [Jaccoud] (Multiple sites)
0.000 0.997 0.003
M12.01 Chronic postrheumatic arthropathy [Jaccoud] (Shoulder region)
0.000 0.997 0.003
M12.02 Chronic postrheumatic arthropathy [Jaccoud] (Upper arm)
0.000 0.997 0.003
M12.03 Chronic postrheumatic arthropathy [Jaccoud] (Forearm)
0.000 0.997 0.003
M12.04 Chronic postrheumatic arthropathy [Jaccoud] (Hand)
0.000 0.997 0.003
M12.05 Chronic postrheumatic arthropathy [Jaccoud] (Pelvic region and thigh)
0.000 0.997 0.003
M12.06 Chronic postrheumatic arthropathy [Jaccoud] (Lower leg)
0.000 0.997 0.003
M12.07 Chronic postrheumatic arthropathy [Jaccoud] (Ankle and foot)
0.000 0.997 0.003
M12.08 Chronic postrheumatic arthropathy [Jaccoud] (Other)
0.000 0.997 0.003
M12.09 Chronic postrheumatic arthropathy [Jaccoud] (Site unspecified)
0.000 0.997 0.003
M12.10 Kaschin-Beck disease (Multiple sites)
0.000 0.997 0.003
M12.11 Kaschin-Beck disease (Shoulder region)
0.000 0.997 0.003
M12.12 Kaschin-Beck disease (Upper arm)
0.000 0.997 0.003
M12.13 Kaschin-Beck disease (Forearm)
0.000 0.997 0.003
M12.14 Kaschin-Beck disease (Hand)
0.000 0.997 0.003
M12.15 Kaschin-Beck disease (Pelvic region and thigh)
0.000 0.997 0.003
M12.16 Kaschin-Beck disease (Lower leg)
0.000 0.997 0.003
M12.17 Kaschin-Beck disease (Ankle and foot)
0.000 0.997 0.003
M12.18 Kaschin-Beck disease (Other)
0.000 0.997 0.003
M12.19 Kaschin-Beck disease (Site unspecified)
0.000 0.997 0.003
M12.40 Intermittent hydrarthrosis (Multiple sites)
0.000 0.997 0.003
M12.41 Intermittent hydrarthrosis (Shoulder region)
0.000 0.997 0.003
M12.42 Intermittent hydrarthrosis (Upper arm)
0.000 0.997 0.003
M12.43 Intermittent hydrarthrosis (Forearm)
0.000 0.997 0.003
M12.44 Intermittent hydrarthrosis (Hand)
0.000 0.997 0.003
M12.45 Intermittent hydrarthrosis (Pelvic region and thigh)
0.000 0.997 0.003
M12.46 Intermittent hydrarthrosis (Lower leg)
0.000 0.997 0.003
M12.47 Intermittent hydrarthrosis (Ankle and foot)
0.000 0.997 0.003
M12.48 Intermittent hydrarthrosis (Other)
0.000 0.997 0.003
M12.49 Intermittent hydrarthrosis (Site unspecified)
0.000 0.997 0.003
M12.80 Other specific arthropathies, not elsewhere classified (Multiple sites)
0.000 0.997 0.003
M12.81 Other specific arthropathies, not elsewhere classified (Shoulder region)
0.000 0.997 0.003
M12.82 Other specific arthropathies, not elsewhere classified (Upper arm)
0.000 0.997 0.003
M12.83 Other specific arthropathies, not elsewhere classified (Forearm)
0.000 0.997 0.003
M12.84 Other specific arthropathies, not elsewhere classified (Hand)
0.000 0.997 0.003
M12.85 Other specific arthropathies, not elsewhere classified (Pelvic region and thigh)
0.000 0.997 0.003
M12.86 Other specific arthropathies, not elsewhere classified (Lower leg)
0.000 0.997 0.003
M12.87 Other specific arthropathies, not elsewhere classified (Ankle and foot)
0.000 0.997 0.003
M12.88 Other specific arthropathies, not elsewhere classified (Other)
0.000 0.997 0.003
M12.89 Other specific arthropathies, not elsewhere classified (Site unspecified)
0.000 0.997 0.003
K86.3 Pseudocyst of pancreas
0.003 0.997 0.000
H04.1 Other disorders of lachrymal gland
0.003 0.997 0.000
Z75.3 Unavailability and inaccessibility of health-care facilities
0.000 0.997 0.003
M07 Psoriatic and enteropathic arthropathies
0.000 0.997 0.003
Z24.0 Need for immunisation against poliomyelitis
0.003 0.997 0.000
Z24.1 Need for immunisation against arthropod-borne viral encephalitis
0.003 0.997 0.000
Z24.2 Need for immunisation against rabies
0.003 0.997 0.000
Z24.3 Need for immunisation against yellow fever
0.003 0.997 0.000
Z24.4 Need for immunisation against measles alone
0.003 0.997 0.000
Z24.6 Need for immunisation against viral hepatitis
0.003 0.997 0.000
M12.50 Traumatic arthropathy (Multiple sites)
0.000 0.997 0.003
M12.51 Traumatic arthropathy (Shoulder region)
0.000 0.997 0.003
M12.52 Traumatic arthropathy (Upper arm)
0.000 0.997 0.003
M12.53 Traumatic arthropathy (Forearm)
0.000 0.997 0.003
M12.54 Traumatic arthropathy (Hand)
0.000 0.997 0.003
M12.55 Traumatic arthropathy (Pelvic region and thigh)
0.000 0.997 0.003
M12.56 Traumatic arthropathy (Lower leg)
0.000 0.997 0.003
M12.58 Traumatic arthropathy (Other)
0.000 0.997 0.003
M12.59 Traumatic arthropathy (Site unspecified)
0.000 0.997 0.003
Q61.2 Polycystic kidney, adult type
0.000 0.997 0.003
U80.1 Methicillin resistant agent
0.000 0.997 0.003
Z23.0 Need for immunisation against cholera alone
0.003 0.997 0.000
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]
0.003 0.997 0.000
Z23.2 Need for immunisation against tuberculosis [BCG]
0.003 0.997 0.000
Z23.3 Need for immunisation against plague
0.003 0.997 0.000
Z23.4 Need for immunisation against tularaemia
0.003 0.997 0.000
Z23.5 Need for immunisation against tetanus alone
0.003 0.997 0.000
Z23.6 Need for immunisation against diphtheria alone
0.003 0.997 0.000
Z23.7 Need for immunisation against pertussis alone
0.003 0.997 0.000
Z23.8 Need for immunisation against other single bacterial diseases
0.003 0.997 0.000
Z25.0 Need for immunisation against mumps alone
0.003 0.997 0.000
Z25.1 Need for immunisation against influenza
0.003 0.997 0.000
Z25.8 Need for immunisation against other specified single viral diseases
0.003 0.997 0.000
Z26.0 Need for immunisation against leishmaniasis
0.003 0.997 0.000
Z26.8 Need for immunisation against other specified single infectious diseases
0.003 0.997 0.000
Z26.9 Need for immunisation against unspecified infectious disease
0.003 0.997 0.000
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]
0.003 0.997 0.000
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]
0.003 0.997 0.000
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]
0.003 0.997 0.000
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]
0.003 0.997 0.000
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]
0.003 0.997 0.000
Z27.8 Need for immunisation against other combinations of infectious diseases
0.003 0.997 0.000
Z27.9 Need for immunisation against unspecified combinations of infectious diseases
0.003 0.997 0.000
Z28.0 Immunisation not carried out because of contraindication
0.003 0.997 0.000
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure
0.003 0.997 0.000
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons
0.003 0.997 0.000
Z28.8 Immunisation not carried out for other reasons
0.003 0.997 0.000
Z28.9 Immunisation not carried out for unspecified reason
0.003 0.997 0.000
S81.9 Open wound of lower leg, part unspecified
0.000 0.997 0.003
C62.9 Testis, unspecified
0.000 0.997 0.003
M84.48 Pathological fracture, not elsewhere classified (Other)
0.003 0.997 0.000
N71.9 Inflammatory disease of uterus, unspecified
0.003 0.997 0.000
M05 Seropositive rheumatoid arthritis
0.000 0.997 0.003
M89.86 Other specified disorders of bone (Lower leg)
0.003 0.997 0.000
S02.80 Fractures of other skull and facial bones (closed)
0.000 0.997 0.003
M12.57 Traumatic arthropathy (Ankle and foot)
0.000 0.997 0.003
F45.8 Other somatoform disorders
0.003 0.997 0.000
M08.00 Juvenile rheumatoid arthritis (Multiple sites)
0.000 0.997 0.003
M08.01 Juvenile rheumatoid arthritis (Shoulder region)
0.000 0.997 0.003
M08.02 Juvenile rheumatoid arthritis (Upper arm)
0.000 0.997 0.003
M08.03 Juvenile rheumatoid arthritis (Forearm)
0.000 0.997 0.003
M08.04 Juvenile rheumatoid arthritis (Hand)
0.000 0.997 0.003
M08.05 Juvenile rheumatoid arthritis (Pelvic region and thigh)
0.000 0.997 0.003
M08.06 Juvenile rheumatoid arthritis (Lower leg)
0.000 0.997 0.003
M08.07 Juvenile rheumatoid arthritis (Ankle and foot)
0.000 0.997 0.003
M08.08 Juvenile rheumatoid arthritis (Other)
0.000 0.997 0.003
M08.09 Juvenile rheumatoid arthritis (Site unspecified)
0.000 0.997 0.003
M08.10 Juvenile ankylosing spondylitis (Multiple sites)
0.000 0.997 0.003
M08.11 Juvenile ankylosing spondylitis (Shoulder region)
0.000 0.997 0.003
M08.12 Juvenile ankylosing spondylitis (Upper arm)
0.000 0.997 0.003
M08.13 Juvenile ankylosing spondylitis (Forearm)
0.000 0.997 0.003
M08.14 Juvenile ankylosing spondylitis (Hand)
0.000 0.997 0.003
M08.15 Juvenile ankylosing spondylitis (Pelvic region and thigh)
0.000 0.997 0.003
M08.16 Juvenile ankylosing spondylitis (Lower leg)
0.000 0.997 0.003
M08.17 Juvenile ankylosing spondylitis (Ankle and foot)
0.000 0.997 0.003
M08.18 Juvenile ankylosing spondylitis (Other)
0.000 0.997 0.003
M08.19 Juvenile ankylosing spondylitis (Site unspecified)
0.000 0.997 0.003
M08.20 Juvenile arthritis with systemic onset (Multiple sites)
0.000 0.997 0.003
M08.21 Juvenile arthritis with systemic onset (Shoulder region)
0.000 0.997 0.003
M08.22 Juvenile arthritis with systemic onset (Upper arm)
0.000 0.997 0.003
M08.23 Juvenile arthritis with systemic onset (Forearm)
0.000 0.997 0.003
M08.24 Juvenile arthritis with systemic onset (Hand)
0.000 0.997 0.003
M08.25 Juvenile arthritis with systemic onset (Pelvic region and thigh)
0.000 0.997 0.003
M08.26 Juvenile arthritis with systemic onset (Lower leg)
0.000 0.997 0.003
M08.27 Juvenile arthritis with systemic onset (Ankle and foot)
0.000 0.997 0.003
M08.28 Juvenile arthritis with systemic onset (Other)
0.000 0.997 0.003
M08.29 Juvenile arthritis with systemic onset (Site unspecified)
0.000 0.997 0.003
M08.30 Juvenile polyarthritis (seronegative) (Multiple sites)
0.000 0.997 0.003
M08.31 Juvenile polyarthritis (seronegative) (Shoulder region)
0.000 0.997 0.003
M08.32 Juvenile polyarthritis (seronegative) (Upper arm)
0.000 0.997 0.003
M08.33 Juvenile polyarthritis (seronegative) (Forearm)
0.000 0.997 0.003
M08.34 Juvenile polyarthritis (seronegative) (Hand)
0.000 0.997 0.003
M08.35 Juvenile polyarthritis (seronegative) (Pelvic region and thigh)
0.000 0.997 0.003
M08.36 Juvenile polyarthritis (seronegative) (Lower leg)
0.000 0.997 0.003
M08.37 Juvenile polyarthritis (seronegative) (Ankle and foot)
0.000 0.997 0.003
M08.38 Juvenile polyarthritis (seronegative) (Other)
0.000 0.997 0.003
M08.39 Juvenile polyarthritis (seronegative) (Site unspecified)
0.000 0.997 0.003
M08.40 Pauciarticular juvenile arthritis (Multiple sites)
0.000 0.997 0.003
M08.41 Pauciarticular juvenile arthritis (Shoulder region)
0.000 0.997 0.003
M08.42 Pauciarticular juvenile arthritis (Upper arm)
0.000 0.997 0.003
M08.43 Pauciarticular juvenile arthritis (Forearm)
0.000 0.997 0.003
M08.44 Pauciarticular juvenile arthritis (Hand)
0.000 0.997 0.003
M08.45 Pauciarticular juvenile arthritis (Pelvic region and thigh)
0.000 0.997 0.003
M08.46 Pauciarticular juvenile arthritis (Lower leg)
0.000 0.997 0.003
M08.47 Pauciarticular juvenile arthritis (Ankle and foot)
0.000 0.997 0.003
M08.48 Pauciarticular juvenile arthritis (Other)
0.000 0.997 0.003
M08.49 Pauciarticular juvenile arthritis (Site unspecified)
0.000 0.997 0.003
M08.80 Other juvenile arthritis (Multiple sites)
0.000 0.997 0.003
M08.81 Other juvenile arthritis (Shoulder region)
0.000 0.997 0.003
M08.82 Other juvenile arthritis (Upper arm)
0.000 0.997 0.003
M08.83 Other juvenile arthritis (Forearm)
0.000 0.997 0.003
M08.84 Other juvenile arthritis (Hand)
0.000 0.997 0.003
M08.85 Other juvenile arthritis (Pelvic region and thigh)
0.000 0.997 0.003
M08.86 Other juvenile arthritis (Lower leg)
0.000 0.997 0.003
M08.87 Other juvenile arthritis (Ankle and foot)
0.000 0.997 0.003
M08.88 Other juvenile arthritis (Other)
0.000 0.997 0.003
M08.89 Other juvenile arthritis (Site unspecified)
0.000 0.997 0.003
M08.90 Juvenile arthritis, unspecified (Multiple sites)
0.000 0.997 0.003
M08.91 Juvenile arthritis, unspecified (Shoulder region)
0.000 0.997 0.003
M08.92 Juvenile arthritis, unspecified (Upper arm)
0.000 0.997 0.003
M08.93 Juvenile arthritis, unspecified (Forearm)
0.000 0.997 0.003
M08.94 Juvenile arthritis, unspecified (Hand)
0.000 0.997 0.003
M08.95 Juvenile arthritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
M08.96 Juvenile arthritis, unspecified (Lower leg)
0.000 0.997 0.003
M08.97 Juvenile arthritis, unspecified (Ankle and foot)
0.000 0.997 0.003
M08.98 Juvenile arthritis, unspecified (Other)
0.000 0.997 0.003
M08.99 Juvenile arthritis, unspecified (Site unspecified)
0.000 0.997 0.003
M09.00 Juvenile arthritis in psoriasis (Multiple sites)
0.000 0.997 0.003
M09.01 Juvenile arthritis in psoriasis (Shoulder region)
0.000 0.997 0.003
M09.02 Juvenile arthritis in psoriasis (Upper arm)
0.000 0.997 0.003
M09.03 Juvenile arthritis in psoriasis (Forearm)
0.000 0.997 0.003
M09.04 Juvenile arthritis in psoriasis (Hand)
0.000 0.997 0.003
M09.05 Juvenile arthritis in psoriasis (Pelvic region and thigh)
0.000 0.997 0.003
M09.06 Juvenile arthritis in psoriasis (Lower leg)
0.000 0.997 0.003
M09.07 Juvenile arthritis in psoriasis (Ankle and foot)
0.000 0.997 0.003
M09.08 Juvenile arthritis in psoriasis (Other)
0.000 0.997 0.003
M09.09 Juvenile arthritis in psoriasis (Site unspecified)
0.000 0.997 0.003
M09.10 Juvenile arthritis in Crohn's disease [regional enteritis] (Multiple sites)
0.000 0.997 0.003
M09.11 Juvenile arthritis in Crohn's disease [regional enteritis] (Shoulder region)
0.000 0.997 0.003
M09.12 Juvenile arthritis in Crohn's disease [regional enteritis] (Upper arm)
0.000 0.997 0.003
M09.13 Juvenile arthritis in Crohn's disease [regional enteritis] (Forearm)
0.000 0.997 0.003
M09.14 Juvenile arthritis in Crohn's disease [regional enteritis] (Hand)
0.000 0.997 0.003
M09.15 Juvenile arthritis in Crohn's disease [regional enteritis] (Pelvic region and thigh)
0.000 0.997 0.003
M09.16 Juvenile arthritis in Crohn's disease [regional enteritis] (Lower leg)
0.000 0.997 0.003
M09.17 Juvenile arthritis in Crohn's disease [regional enteritis] (Ankle and foot)
0.000 0.997 0.003
M09.18 Juvenile arthritis in Crohn's disease [regional enteritis] (Other)
0.000 0.997 0.003
M09.19 Juvenile arthritis in Crohn's disease [regional enteritis] (Site unspecified)
0.000 0.997 0.003
M09.20 Juvenile arthritis in ulcerative colitis (Multiple sites)
0.000 0.997 0.003
M09.21 Juvenile arthritis in ulcerative colitis (Shoulder region)
0.000 0.997 0.003
M09.22 Juvenile arthritis in ulcerative colitis (Upper arm)
0.000 0.997 0.003
M09.23 Juvenile arthritis in ulcerative colitis (Forearm)
0.000 0.997 0.003
M09.24 Juvenile arthritis in ulcerative colitis (Hand)
0.000 0.997 0.003
M09.25 Juvenile arthritis in ulcerative colitis (Pelvic region and thigh)
0.000 0.997 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.